|
**Overview**: Galactosemia Classical Panel**Introduction**: The Galactosemia Classical Panel is a diagnostic tool designed to screen for classical galactosemia using whole blood samples. In India, classical galactosemia (GALT deficiency) is rare (~1 in 30,000â€"60,000 births) but underdiagnosed in neonates with feeding intolerance, jaundice, E. coli sepsis, or cataracts, leading to liver failure or death if untreated. High morbidity from delayed diagnosis in rural/low-SES newborns, limited newborn screening, delayed lactose-free formula leading to irreversible brain damage or ovarian failure in females. Per molecular pathology practices aligned with ICMR and Indian Society of Human Genetics guidelines, the test employs PCR for GALT gene mutations and enzyme activity over 1-2 days with high accuracy, valuable for confirming diagnosis in symptomatic neonates or family screening. This diagnostic falls under genetic disorder screening and targets newborns with feeding issues or sepsis, addressing accurate detection to guide dietary management and genetic counseling. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification and reducing neonatal mortality. Its whole blood-based approach ensures reliable enzyme/mutation analysis.**Other Names**: Galacto Class Pnl.**FDA Status**: FDA approved, CLIA certified for molecular pathology/cytogenetics, compliant with 2025 standards.**Historical Milestone**: GALT testing standard; in India, expanding in neonatal screening.**Purpose**: The test assesses 2 parameters including GALT enzyme activity to guide classical galactosemia screening, confirm deficiency, inform diet.**Test Parameters**: 1. GALT Enzyme Activity, 2. GALT Gene Mutation.**Pretest Condition**: No fasting required; patients should be symptomatic neonates or carriers.**Specimen**: 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 48 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not applicable (fresh sample preferred for analysis).**Medical History**: Patients should provide details on neonatal jaundice, vomiting, sepsis.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated galactosemia including liver failure, benefits of early detection, and minimal discomfort from blood draw.**Procedural Considerations**: The test involves sample processing using PCR and enzyme assay by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or recent milk exposure can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low GALT activity/mutation confirms classical galactosemia, necessitating specialist input. Normal may require follow-up.**Specialist Consultation**: Pediatricians or geneticists should be consulted for management.**Additional Supporting Tests**: Galactose-1-phosphate, urine reducing substances for confirmation.**Test Limitations**: Enzyme activity affected by diet; comprehensive approach required.**References**: Indian Journal of Pediatrics 2024, Metabolic Studies India 2023. |
